Financials
Financial year 2025
DCV PHARMA from Lier, company number BE0807314964, closed financial year 2025 with a result of € -226,029 after tax. For that financial year DCV PHARMA recorded a gross margin of € 70,651 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 102,606 to € -226,029. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.
€ 1.3 million
▼ 15% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -226,029
▼ still € 102,606 profit in 2024
Profit after tax over the fiscal year.
€ 933,093
▲ € 898,254 vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 1.3 million.
People and assets in 2025
€ 18,262
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 8,652
▲ € 8,226 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 3,476
▼ 92% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 218,749 | € 226,624 | € 194,117 | € 70,651 | ▼ 64% |
| Profit after taxes | € 111,542 | € 120,925 | € 102,606 | € -226,029 | ▼ € 328,635 |
| Equity | € 1,344,954 | € 1,465,880 | € 1,528,486 | € 1,302,456 | ▼ 15% |
| Total debts | € 922,682 | € 807,038 | € 727,817 | € 37,160 | ▼ 95% |
| Cash | € 12,464 | € 5,416 | € 34,838 | € 933,093 | ▲ € 898,254 |
| Land & buildings | € 114,461 | € 98,587 | € 82,714 | € 66,840 | ▼ 19% |
| Retained profit | € 1,338,754 | € 1,459,680 | € 1,522,286 | € 1,296,256 | ▼ 15% |
| Dividend | € 0 | € 0 | € 40,000 | € 0 | ▼ 100% |
| Bank debt | € 786,069 | € 659,108 | € 526,406 | € 0 | ▼ 100% |
| Balance sheet total | € 2,267,636 | € 2,272,918 | € 2,256,302 | € 1,339,617 | ▼ 41% |
Key figures of DCV PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DCV PHARMA?
What happened at DCV PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 226,029 (▼ € 328,635 vs 2024). Source: NBB ↗
- New establishment in Boechout. KBO
- New establishment in Lier. KBO
- Start of the company according to the CBE. KBO
In short
From € 111,542 profit in 2022 to € 226,029 loss in 2025.
Paid € 140,547 in corporate taxes since 2022.
Best year ever: 2023, with € 120,925 profit.
Paid out € 40,000 in dividends to the owners in total.
Management
Behind DCV PHARMA is Bram De Clercq. Bram De Clercq is also behind APOTHEEK SINT BAVO.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Arbeidsstraat 44
2500 Lier
Botertonstraat 3 box 8
2500 Lier
Active since 14 October 2008
Heuvelstraat 96
2530 Boechout
Active since 1 April 2010
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0807.314.964
- VAT number
- BE 0807.314.964
- Registered office
- Arbeidsstraat 44, 2500 Lier
- Names & denominations
- DCV PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 October 2008
- Peppol
- Active · Active since 27 Oct 2025
- Activities · NACE
Activiteiten van holdings
Holdings
Detailhandel in cosmetica en toiletartikelen
Groothandel in parfumerieën en cosmetica